Page 57 - IJB-10-5
P. 57

International Journal of Bioprinting                                  Medical regenerative in situ bioprinting




            vitro pre-printing and incubation requirements, reduces   concise comparison of these techniques is provided in
            contamination risks, and enables real-time adjustments   Table 1. Herein, we shall compare the two aforementioned
            according to the printed structures. Compared with   in situ bioprinting systems (i.e., RASBS and HISBS) in
            conventional bioprinting, the strategy can precisely match   detail across multiple aspects (Table 2).
            the shape of the wound, crosslink  in situ for adhesion
            without  in vitro culture, facilitate rapid repairment, and   2.1. Robotic-assisted in situ bioprinting system
            minimize fibrosis. 30–32  Furthermore, in situ bioprinting can   2.1.1. System setup
            exploit the human body’s regenerative potential, providing   Robotic-assisted in situ bioprinting systems (RASBS) are
            the physiological environment required for scaffold   an emerging method for fabricating 3D structures using
            culture.  In situ bioprinting systems can be divided into two   software codes, reducing human intervention and ensuring
                  33
            major categories: robotic-assisted in situ bioprinting system   higher printing accuracy. The key factors affecting the
            (RASBS) (Figure 1A) and handheld  in situ bioprinting   quality of the printed structure include printing speed,
            system (HISBS) (Figure 1B). RASBS can be programmed   stability, and repeatable positioning accuracy. The
            by computer-aided manufacturing (CAM) and usually be   printing speed encompasses both the moving speed of
            used in less mobile environments. This strategy has many   the printhead and the extrusion speed of the material,
            advantages, such as high precision, 35,36  multi-material   and these parameters require optimization based on the
            in situ printing for significant composite defects,  and   rheological properties of the material.  For example, a
                                                     37
                                                                                               60
            compatibility with minimally invasive surgery,  but is also   high moving speed and low extrusion speed will produce
                                                 38
            time-consuming and requires sophisticated equipment.
            HISBS is an alternative strategy for in situ bioprinting that   discontinuous  lines;  a  low  moving  speed  and  high
            is easy  to use without the need for complex  equipment   extrusion speed will produce clustered lines. The stability
            and expertise. Although HISBS has a relatively lower   of the printing structure mainly depends on the physical
            printing resolution and limited multi-material processing   and chemical properties of the material, highlighting
                                                                                                            61
            ability due to the compromise for portability, it has the   the  importance  of  selecting  the  appropriate  bioink.
            potential to meet specific requirements of emergency   Repeatable positioning accuracy sets high requirements
            clinical applications. Minimally invasive in situ bioprinting   for in situ bioprinting systems, necessitating robot-assisted
            combines robotic assistance and human control for non-  positioning combined with computer vision and sensors to
            invasive printing in vivo.                         further improve positioning accuracy. 62
               In  situ 3D bioprinting has been demonstrated to   Nonetheless, RASBS offers a range of advantages, such
                                                                                                     24
            effectively repair tissue defects, addressing the problems of   as: (i) superior printing accuracy and dexterity  that are
            mismatched structures from conventional 3D bioprinting   crucial for achieving a precise fit with the exact shape
            and reducing infection risks, while simplifying the   of the wound; (ii) rapid production of complex multi-
            surgical procedure. Despite existing reviews on  in situ   material structures, 63,64  especially in critical situations that
            3D bioprinting technology, recent research has reported   necessitate emergency treatment, such as in battlefield or
                                                                                                            65
            new advancements in this technology, highlighting its   accident scenarios;  (iii)  reduced human  intervention,
            potential to enhance tissue repair and better promote   as RASBS can automate the bioprinting process using
            its clinical application. These studies focus on ensuring   computer-aided robotic arms and digital models; (iv)
            the precise fit and mechanical integrity of structures   seamless integration with minimally invasive surgical
                                                                        29
            for  irregularly shaped wounds,  optimizing  the  printing   techniques,  including endoscopy, facilitating inside
            path, real-time monitoring of the printing process, and   body printing; (v) compatibility with process monitoring
            accurately positioning and curing bioinks in deep tissues   systems and machine learning techniques, 65–67  contributing
            in vivo. Herein, this article reviews the utilization of in situ   to error reduction during the printing process; and (vi)
            bioprinting in real-time monitoring and the optimization   enhanced cell viability by minimizing the exposure of
            of printing performance in terms of automatic printing,   printed cells to external environmental conditions, while
            handheld printing, human-controlled machine assisted in   the  complex  topological  structures  aid  in  regulating  the
            situ bioprinting and bioinks.                      spatial distribution and growth of cells.
                                                                  Most reported RASBS are made up of robotic arms, 65,68–71
            2. Strategies of in situ bioprinting               but some automated in situ bioprinting platforms are made
            The bioprinting techniques used for  in situ bioprinting   up of framework-based systems. 32,72  The  in situ printing
            include inkjet bioprinting, 37,39  laser-assisted bioprinting   system based on the robotic arm can utilize either multi-
            (LAB), 40,41  extrusion bioprinting, 42,43  stereolithography-  axis rigid robot arms 38,73  or flexible robot arms.  During
                                                                                                      74
            based (SLA) bioprinting, 44,45  and electrospinning. 46,47  A   the printing process, the structure is printed by computer-

            Volume 10 Issue 5 (2024)                        49                                doi: 10.36922/ijb.3366
   52   53   54   55   56   57   58   59   60   61   62